Common Contracts
2 similar License Agreement contracts by Zenas BioPharma, Inc.
FIRST AMENDMENT TO LICENSE AGREEMENT BETWEEN XENCOR, INC. AND ZENAS BIOPHARMA (CAYMAN) LIMITEDLicense Agreement • August 22nd, 2024 • Zenas BioPharma, Inc. • Pharmaceutical preparations
This First Amendment (this “Amendment”) to the License Agreement entered into as of May 27, 2021 by and between Xencor, Inc. (“Xencor”) and Zenas BioPharma (Cayman) Limited (“Zenas”) (the “Agreement”) is entered into and made effective as of November 3, 2021 (the “Amendment Effective Date”). Capitalized terms used but not otherwise defined herein will have the meanings ascribed to such terms in the Agreement.
FIRST AMENDMENT TO LICENSE AGREEMENT BETWEEN XENCOR, INC. AND ZENAS BIOPHARMA (CAYMAN) LIMITEDLicense Agreement • January 25th, 2024 • Zenas BioPharma, Inc. • Pharmaceutical preparations
This First Amendment (this “Amendment”) to the License Agreement entered into as of May 27, 2021 by and between Xencor, Inc. (“Xencor”) and Zenas BioPharma (Cayman) Limited (“Zenas”) (the “Agreement”) is entered into and made effective as of November 3, 2021 (the “Amendment Effective Date”). Capitalized terms used but not otherwise defined herein will have the meanings ascribed to such terms in the Agreement.
